Thyroid Cancer Information
Thyroid cancer is a rare malignancy that develops in the thyroid gland. Survival rates are encouragingly high; nearly 100 percent of patients who are diagnosed with early-stage thyroid cancer survive at least five years after their diagnosis, according to the American Cancer Society. Even in situations where the cancer has spread to the lymph nodes outside of the thyroid gland, five-year survival rates are still nearly 98 percent.
At Tampa General Hospital, patients with thyroid cancer can access the newest and most effective treatments throughout our ear, nose, and throat oncology program. We offer minimally invasive and robotic surgeries, external beam and internal radiation therapy, individualized chemotherapy prescriptions, and a complete range of supportive care services all in a single, convenient location. Additionally, we:
Have a highly experienced team of oncologists that exclusively treats patients with cancers of the head and neck, giving them notable expertise in the field of thyroid cancer treatment.
Take an individualized approach to treatment, creating customized therapy plans for each patient based on factors such as the size, stage, and location of the tumor.
Respect how crucial prompt treatment is, and therefore have a short average wait time for new oncology appointments.
In recognition of our comprehensive approach to care, Tampa General Hospital was named one of America's Best Hospitals for Diabetes & Endocrinology and a High Performing Hospital for Cancer by U.S. News & World Report in 2020-2021.
For a physician referral, use our Physician Finder tool or call 813-844-7585.